Intellective Biologics (Suzhou) Co., Ltd.
PrivateLast Round
Series C
Extension
Jan 20, 2023
Est. Valuation
$873M
Total Funding Raised
$112M
Company Overview
Intellective Biologics (Suzhou) Co., Ltd. operates in Healthcare & Life Sciences and is based in Suzhou. Its latest recorded funding round was a Series C Extension round in January 2023.
Intellective Biologics (Suzhou) Co., Ltd. is a biotechnology company that operates as a contract development and manufacturing organization (CDMO) providing one-stop services from process development to commercial manufacturing for biologics.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Pharma Supply Chain
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Infrastructure
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Intellective Biologics (Suzhou) Co., Ltd. Comparables
Compare Intellective Biologics (Suzhou) Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| WuXi Biologics | 85% | |
| Innovent Biologics | 80% | |
| GenScript | 80% |
For institutional investors. Book with your work email.
Intellective Biologics (Suzhou) Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C Extension | Jan 20, 2023 | ||||
| Series C | Aug 4, 2022 | ||||
| Series B Extension | Sep 1, 2021 | ||||
| Series B | Jun 28, 2021 | ||||
| Series A Extension | May 7, 2021 | ||||
Series A | Nov 1, 2020 |
For institutional investors. Book with your work email.
Intellective Biologics (Suzhou) Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| BioTrack Capital | Series B, Series A, Series B Extension |
| Qingsong Fund | Series A, Series B Extension |
| Legend Capital | Series B, Series A, Series B Extension |
| Gaorong Capital | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 4, 2022
$74M round led by Gaorong Capital
- Sep 1, 2021
Raised capital from BioTrack Capital, Legend Capital, and Qingsong Fund.
For institutional investors. Book with your work email.
Intellective Biologics (Suzhou) Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Intellective Biologics (Suzhou) Co., Ltd.'s valuation, stock price, and market status.
Is Intellective Biologics (Suzhou) Co., Ltd. a public or private company?
Intellective Biologics (Suzhou) Co., Ltd. is a private company.
What is the current stock price of Intellective Biologics (Suzhou) Co., Ltd.?
Intellective Biologics (Suzhou) Co., Ltd. is a private company, so its shares have no public market price. Caplight tracks Intellective Biologics (Suzhou) Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Intellective Biologics (Suzhou) Co., Ltd. worth (valuation)?
Intellective Biologics (Suzhou) Co., Ltd.'s valuation is estimated at $873.0M based on funding round data.
Can I buy Intellective Biologics (Suzhou) Co., Ltd. stock?
Intellective Biologics (Suzhou) Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Intellective Biologics (Suzhou) Co., Ltd.'s last funding round?
Intellective Biologics (Suzhou) Co., Ltd.'s most recent funding round was Series C Extension on January 20, 2023.
Who are the main investors in Intellective Biologics (Suzhou) Co., Ltd.?
Key investors in Intellective Biologics (Suzhou) Co., Ltd. include Gaorong Capital.
Will Intellective Biologics (Suzhou) Co., Ltd. IPO soon?
No public IPO plans have been announced for Intellective Biologics (Suzhou) Co., Ltd..
How can I track Intellective Biologics (Suzhou) Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades in Intellective Biologics (Suzhou) Co., Ltd.'s shares on secondary markets.